testosterone propionate has been researched along with clobetasol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Ayhan, A; Gultekin, M; Guven, S; Guvendag Guven, ES; Kucukali, T; Sakinci, M | 1 |
| Ayhan, A; Dogan, NU; Guven, ES; Guven, S; Kucukali, T; Sakinci, M | 1 |
| Baldo, M; Brackenbury, F; Chi, CC; Kirtschig, G; Lewis, F; Wojnarowska, F | 1 |
1 review(s) available for testosterone propionate and clobetasol
| Article | Year |
|---|---|
Topical interventions for genital lichen sclerosus.
Topics: Adult; Anti-Inflammatory Agents; Child; Clobetasol; Dermatologic Agents; Dihydrotestosterone; Female; Genital Diseases, Male; Humans; Lichen Sclerosus et Atrophicus; Male; Mometasone Furoate; Pregnadienediols; Randomized Controlled Trials as Topic; Tacrolimus; Testosterone Propionate; Vulvar Lichen Sclerosus | 2011 |
3 other study(ies) available for testosterone propionate and clobetasol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Topical testosterone versus clobetasol for vulvar lichen sclerosus.
Topics: Administration, Topical; Adult; Androgens; Clobetasol; Female; Glucocorticoids; Humans; Middle Aged; Recurrence; Retrospective Studies; Testosterone Propionate; Vulvar Lichen Sclerosus | 2007 |
Testosterone versus clobetasol for maintenance of vulvar lichen sclerosus associated with variable degrees of squamous cell hyperplasia.
Topics: Adult; Aged; Aged, 80 and over; Clobetasol; Female; Glucocorticoids; Humans; Hyperplasia; Middle Aged; Retrospective Studies; Secondary Prevention; Testosterone Propionate; Vulvar Lichen Sclerosus | 2007 |